Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.04 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced outside the brain (hepatocytes) | 0.10 |
| chemistry Open Targets | compounds already reach it: e2.3, pabinafusp alfa | 0.72 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 7 Parkinson's papers of 513 | 0.73 |
| pathways Reactome | 1 pathway; mostly vesicle traffic | 1.00 |
No case: the score is under the bar. Receipt 5926
Sealed predictions
- TFR2 in dopamine neurons, braak-0.56 (p 0.119) → +0.06 (p 0.874)receipt 5934
Swarm cases
receipt 5934: TFR2 in dopamine neurons, braak
- power
- full sample -0.34 (p 0.170, n 18), 95% CI -0.70 to +0.15. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.33 (p 0.185, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.32 (p 0.191, n 18). could be the mix.
- skeptic
- leave-one-out range -0.47 to -0.25, sign flips 0; without severely affected donors -0.34 (p 0.170, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for TFR2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts